Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$12.15 - $35.28 $1.9 Million - $5.5 Million
-156,000 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$41.56 - $59.88 $4.07 Million - $5.86 Million
-97,900 Reduced 38.56%
156,000 $7.52 Million
Q4 2020

Feb 02, 2021

SELL
$36.08 - $56.47 $2.09 Million - $3.28 Million
-58,000 Reduced 18.6%
253,900 $13.7 Million
Q3 2020

Nov 10, 2020

SELL
$33.26 - $40.48 $1.71 Million - $2.08 Million
-51,300 Reduced 14.12%
311,900 $11.5 Million
Q2 2020

Aug 12, 2020

BUY
$24.21 - $31.02 $3.62 Million - $4.64 Million
149,600 Added 70.04%
363,200 $11.3 Million
Q1 2020

May 13, 2020

BUY
$20.5 - $34.53 $2.38 Million - $4.01 Million
116,200 Added 119.3%
213,600 $5.9 Million
Q4 2019

Feb 12, 2020

BUY
$18.96 - $29.84 $1.85 Million - $2.91 Million
97,400 New
97,400 $2.85 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.